Agendia BV, Amsterdam, The Netherlands, which specializes in the rapidly evolving field of cancer molecular diagnostics, has appointed six internationally-recognized scientists to its new clinical and scientific advisory board.
The board members, who offer their research and clinical expertise, review early research programs and provide critical evaluations from academic and clinical perspectives.
The new appointees include scientists from the Stanford University School of Medicine, Stanford, Calif; the Lawrence Berkeley National Laboratory, Berkeley, Calif; and the Baylor College of Medicine, Houston.
